During the past decade, Uludag University Medical Faculty conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 10 clinical trials were completed, i.e. on average, 32.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 9 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Uludag University Medical Faculty" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Celgene" with 5 trials sponsored, "Uludag University" with 3 trials sponsored, "Diskapi Teaching and Research Hospital" with 2 trials sponsored and "Abbott Nutrition" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Uludag University Medical Faculty" #1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bursa Medicana Hospital" with 1 trials as a collaborator and "CenTrial GmbH" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Uludag University Medical Faculty" are "Crohn Disease" (4 trials), "Arthritis, Psoriatic" (3 trials), "Blood Transfusion" (2 trials), "Depressive Disorder, Major" (2 trials) and "Idiopathic Pulmonary Fibrosis" (2 trials). Many other conditions were trialed in "Uludag University Medical Faculty" in a lesser frequency.

Most popular intervention types in "Uludag University Medical Faculty" are "Drug" (22 trials), "Other" (11 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Guselkumab" (3 trials), "Ozanimod" (3 trials), "Blood transfusion" (2 trials) and "Amino Acid Supplement Group" (1 trials). Other intervention names were less common.

The vast majority of trials in "Uludag University Medical Faculty" are 31 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Uludag University Medical Faculty". undefined are not yet recruiting, 9 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Uludag University Medical Faculty, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Uludag University Medical Faculty, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".